<DOC>
	<DOCNO>NCT00058032</DOCNO>
	<brief_summary>RATIONALE : Screening test may help doctor detect cancer cell early plan effective treatment cancer . It yet know ultrasound effective without measure CA 125 level detect ovarian cancer postmenopausal woman . PURPOSE : Randomized clinical trial study effectiveness ultrasound without measure CA 125 level detect ovarian cancer postmenopausal woman .</brief_summary>
	<brief_title>CA 125 Ultrasound Detecting Ovarian Cancer Postmenopausal Women</brief_title>
	<detailed_description>OBJECTIVES : - Determine impact preclinical detection ovarian cancer screen ovarian cancer mortality postmenopausal woman . - Determine physical morbidity ovarian cancer screen population . - Determine psychological consequence screen result ( true negative , true positive , false negative , false positive ) population . - Compare intervention result screen ovarian cancer use CA 125 monitoring ultrasound population . - Compare feasibility population screening , term compliance rate annual screen ovarian cancer strategy . - Compare performance screen strategy population . OUTLINE : This randomize , multicenter study . Participants randomize 1 3 screening arm . - Arm I : Participants undergo screen . - Arm II : Participants undergo screen annual CA 125 level . Depending result test , patient may undergo additional screening . - Arm III : Participants undergo screen annual transvaginal transabdominal ultrasound . Depending result test , patient may undergo additional screening . Participants arm complete health questionnaire 3.5 7 year study entry . PROJECTED ACCRUAL : A total 200,000 participant ( 100,000 arm I 50,000 arm II III ) accrue study within 3 year .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Postmenopausal , define meet 1 follow criterion : More 12 month amenorrhea natural menopause hysterectomy Received 12 month hormone replacement therapy menopausal symptoms No prior ovarian malignancy No prior bilateral oophorectomy Not high risk ovarian cancer due familial predisposition define UKCCCR Familial Ovarian Cancer Screening Study PATIENT CHARACTERISTICS : Age 50 74 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No active nonovarian malignancy Prior malignancy allow provide documented persistent recurrent disease patient receive treatment 1 year PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy See Disease Characteristics Radiotherapy Not specify Surgery See Disease Characteristics Other No concurrent participation ovarian cancer screening study</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>ovarian epithelial cancer</keyword>
</DOC>